ASCL1 and prostate cancer: In closing, we report a robust, scalable platform for studying lineage plasticity in a format amenable to deep molecular interrogation and perturbation and identify Ascl1 as a critical gatekeeper of NE transformation and tumor heterogeneity in prostate cancer.